Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 8 October 2017
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 8 October 2017. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that the Board of Directors of the Company has decided to enter into a non-binding Memorandum of Understanding (MOU) under which Beximco Pharma may acquire a majority shareholding (85.22%) in Nuvista Pharma Ltd. a leading pharma Company in Bangladesh specializing in hormones and steroid drugs (the proposed acquisition). The proposed acquisition remains subject to due diligence and negotiation and completion of a definitive Sale and Purchase Agreement. (cont. 1)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005e8b5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.